Table 3.
Evidence overview of prostatic urethral lift versus TURP
| Outcome | Number of trials (evaluated) | Intervention | Control | Absolute risk difference (95% CI) | Relative risk (95% CI) | Quality of evidence |
|---|---|---|---|---|---|---|
| % (n/N) or mean change | % (n/N) or mean change | |||||
| Responders, based on IPSS reduction of ≥30% | 1 (73) | 73 (30/41) | 91 (29/32) | Greater with TURP | 0.8 (0.7–1.0) | Lowa, b |
| –17.5% (–34.4 to –0.5) | ||||||
| IPSS, mean change from baseline: long-term follow-up (>12 mo) | 1 (69) | –9.2 points | –15.3 points | Greater with TURP | Lowa, b | |
| MD 6.1 (2.2–10.0) | ||||||
| IPSS-QoL, mean change from baseline: long-term follow-up (>12 mo) | 1 (69) | –2.5 points | –3.3 points | MD 0.8 (–0.0 to 1.6) | Lowa, c | |
| Need for reoperation (2 yr) | 1 (79) | 14 (6/44) | 6 (2/35) | 8.0% (–4.8 to 20.6) | 2.4 (0.5–11.1) | Very lowa, d |
| Transfusion | NR | |||||
| Urinary incontinence e | 1 (79) | 2 (1/44) | 17 (6/35) | –15.0% (–28.1 to –1.6) | 0.1 (0.02–1.1) | Very low a, d |
CI = confidence intervals; IPSS = International Prostate Symptom Score; MD = mean difference; NR = not reported; QoL = quality of life; TURP = transurethral resection of the prostate.
Downgraded based on the following:
a
Risk of bias (moderate).
b
Imprecision.
c
Very wide confidence.
d
Very wide confidence interval and few events.
e
Clavien-Dindo grade 1.